Anusha Sultan Meo
About
In The Last Decade
Anusha Sultan Meo
28 papers receiving 853 citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Infectious Diseases 427
- Health 131
- Molecular Biology 124
- Modeling and Simulation 106
- Health, Toxicology and Mutagenesis 69
Countries citing papers authored by Anusha Sultan Meo
This map shows the geographic impact of Anusha Sultan Meo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anusha Sultan Meo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anusha Sultan Meo more than expected).
Fields of papers citing papers by Anusha Sultan Meo
This network shows the impact of papers produced by Anusha Sultan Meo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anusha Sultan Meo. The network helps show where Anusha Sultan Meo may publish in the future.
Co-authorship network of co-authors of Anusha Sultan Meo
This figure shows the co-authorship network connecting the top 25 collaborators of Anusha Sultan Meo. A scholar is included among the top collaborators of Anusha Sultan Meo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anusha Sultan Meo. Anusha Sultan Meo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 29 | |
| 9 | 8 | |
| 10 | 1 | |
| 11 | Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics | 81 |
| 12 | 26 | |
| 13 | 4 | |
| 14 | 46 | |
| 15 | COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. breakdown → | 404 |
| 16 | 81 | |
| 17 | 2 | |
| 18 | 2 | |
| 19 | 36 | |
| 20 | 28 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.